184 related articles for article (PubMed ID: 16458519)
21. Synthesis and cytotoxic activities of novel hybrid 2-phenyl-3-alkylbenzofuran and imidazole/triazole compounds.
Chen W; Deng XY; Li Y; Yang LJ; Wan WC; Wang XQ; Zhang HB; Yang XD
Bioorg Med Chem Lett; 2013 Aug; 23(15):4297-302. PubMed ID: 23800685
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.
Foti RS; Diaz P; Douguet D
J Enzyme Inhib Med Chem; 2016; 31(sup2):148-161. PubMed ID: 27424662
[TBL] [Abstract][Full Text] [Related]
23. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and structure-activity relationships of 1-phenyl-1H-1,2,3-triazoles as selective insect GABA receptor antagonists.
Alam MS; Kajiki R; Hanatani H; Kong X; Ozoe F; Matsui Y; Matsumura F; Ozoe Y
J Agric Food Chem; 2006 Feb; 54(4):1361-72. PubMed ID: 16478261
[TBL] [Abstract][Full Text] [Related]
25. Organocatalytic synthesis and sterol 14alpha-demethylase binding interactions of enantioriched 3-(1H-1,2,4-triazol-1-yl)butyl benzoates.
Ming ZH; Xu SZ; Zhou L; Ding MW; Yang JY; Yang S; Xiao WJ
Bioorg Med Chem Lett; 2009 Jul; 19(14):3938-40. PubMed ID: 19329311
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antimicrobial activity of some novel derivatives of benzofuran: part 1. Synthesis and antimicrobial activity of (benzofuran-2-yl)(3-phenyl-3-methylcyclobutyl) ketoxime derivatives.
Koca M; Servi S; Kirilmis C; Ahmedzade M; Kazaz C; Ozbek B; Otük G
Eur J Med Chem; 2005 Dec; 40(12):1351-8. PubMed ID: 16129517
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, antitumor activity and molecular docking study of novel benzofuran-2-yl pyrazole pyrimidine derivatives.
El-Zahar MI; Adb El-Karim SS; Haiba ME; Khedr MA
Acta Pol Pharm; 2011; 68(3):357-73. PubMed ID: 21648190
[TBL] [Abstract][Full Text] [Related]
28. 1,4-Diaryl-substituted triazoles as cyclooxygenase-2 inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Kaur J; Bhardwaj A; Sharma SK; Wuest F
Bioorg Med Chem; 2013 Jul; 21(14):4288-95. PubMed ID: 23706267
[TBL] [Abstract][Full Text] [Related]
29. Comparative structure-activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition.
Sakya SM; Shavnya A; Cheng H; Li C; Rast B; Li J; Koss DA; Jaynes BH; Mann DW; Petras CF; Seibel SB; Haven ML; Lynch MP
Bioorg Med Chem Lett; 2008 Feb; 18(3):1042-5. PubMed ID: 18182290
[TBL] [Abstract][Full Text] [Related]
30. 2 D - QSAR studies on CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]- 1 H-triazoles.
Yadav M
Bioinformation; 2011; 7(8):388-92. PubMed ID: 22347780
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and antifungal activity of novel conformationally restricted triazole derivatives.
Wang W; Sheng C; Che X; Ji H; Miao Z; Yao J; Zhang WN
Arch Pharm (Weinheim); 2009 Dec; 342(12):732-9. PubMed ID: 19899102
[TBL] [Abstract][Full Text] [Related]
32. The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.
Vanden Bossche H; Ausma J; Bohets H; Vermuyten K; Willemsens G; Marichal P; Meerpoel L; Odds F; Borgers M
Antimicrob Agents Chemother; 2004 Sep; 48(9):3272-8. PubMed ID: 15328084
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of some triazolyl-benzofuranamine derivatives.
Turan-Zitouni G; Kaplancikli ZA; Ozdemir A
Farmaco; 2002 Jul; 57(7):573-5. PubMed ID: 12164217
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization and antimicrobial activity of some substituted 1,2,3-triazoles.
Holla BS; Mahalinga M; Karthikeyan MS; Poojary B; Akberali PM; Kumari NS
Eur J Med Chem; 2005 Nov; 40(11):1173-8. PubMed ID: 15979767
[TBL] [Abstract][Full Text] [Related]
35. Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
Röhrig UF; Majjigapu SR; Grosdidier A; Bron S; Stroobant V; Pilotte L; Colau D; Vogel P; Van den Eynde BJ; Zoete V; Michielin O
J Med Chem; 2012 Jun; 55(11):5270-90. PubMed ID: 22616902
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents.
Küçükgüzel I; Tatar E; Küçükgüzel SG; Rollas S; De Clercq E
Eur J Med Chem; 2008 Feb; 43(2):381-92. PubMed ID: 17583388
[TBL] [Abstract][Full Text] [Related]
37. An efficient and convenient synthesis of ethyl 1-(4-methoxyphenyl)-5-phenyl-1H-1,2,3-triazole-4-carboxylate.
Chen JH; Liu SR; Chen K
Chem Asian J; 2010 Feb; 5(2):328-33. PubMed ID: 20029887
[TBL] [Abstract][Full Text] [Related]
38. Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone.
Roman G; Rahman MN; Vukomanovic D; Jia Z; Nakatsu K; Szarek WA
Chem Biol Drug Des; 2010 Jan; 75(1):68-90. PubMed ID: 19954435
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors.
Doiron J; Soultan AH; Richard R; Touré MM; Picot N; Richard R; Cuperlović-Culf M; Robichaud GA; Touaibia M
Eur J Med Chem; 2011 Sep; 46(9):4010-24. PubMed ID: 21703734
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of novel 1, 2, 4-substituted triazoles for urease and anti-proliferative activity.
Ali S; Siddiqui SZ; Abbasi MA; Aziz-Ur-Rehman -; Ali Shah SA; Mohammed Khan K; Saleem RSZ; Manzoor S; Ashraf M; Zia-Ur-Rehman -
Pak J Pharm Sci; 2022 Jan; 35(1(Supplementary)):209-217. PubMed ID: 35228179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
